Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony- stimulating factor receptor mutation derived from a patient with severe congenital neutropenia

Journal of Clinical Investigation

Volumn 102, Issue 3, 1998, Pages 483-492

  McLemore, Morgan L ^a   Poursine Laurent, Jennifer ^a   Link, Daniel C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Leukemia; Mice, transgenic; Neutropenia congenital; Point mutations; Receptors, granulocytic colonystimulating factor

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE TARGETING; LEUKOPOIESIS; MOUSE; NEUTROPENIA; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0032146530     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3216     Document Type: Article

References (42)

1. Kostmann, R. 1956. Infantile genetic agranulocytosis: a new recessive lethal disease in man. Acta Paediatr. 105:1-78.
2. Welte, K., and D. Dale. 1996. Pathophysiology and treatment of severe chronic neutropenia. Ann. Hematol. 72:158-165.
3. Dale, D.C., M.A. Bonilla, M.W. Davis, A.M. Nakanishi, W.P. Hammond, J. Kurtzberg, W. Wang, A. Jakubowski, E. Winton, P. Lalezari, et al. 1993. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood. 81:2496-2502.
4. Bonilla, M.A., D. Dale, C. Zeidler, L. Last, A. Reiter, M. Ruggeiro, M. Davis, B. Koci, W. Hammond, A. Gillio, et al. 1994. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br. J. Haematol. 88:723-730.
5. Mempel, K., T. Pietsch, T. Menzel, C. Zeidler, and K. Welte. 1991. Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia. Blood. 77:1919-1922.
6. Bernhardt, T.M., E.R. Burchardt, and K. Welte. 1993. Assessment of G-CSF and GM-CSF mRNA expression in peripheral blood mononuclear cells from patients with severe congenital neutropenia and in human myeloid leukemic cell lines. Exp. Hematol. 21:163-168.
7. Guba, S.C., C.A. Sartor, R. Hutchinson, L.A. Boxer, and S.G. Emerson. 1994. Granulocyte colony-stimulating factor (G-CSF) production and G-CSF receptor structure in patients with congenital neutropenia. Blood. 83:1486-1492.
8. Sandoval, C., E. Parganas, W. Wang, J.N. Ihle, and P. Adams-Graves. 1995. Lack of alterations in the cytoplasmic domains of the granulocyte colony-stimulating factor receptors in eight cases of severe congenital neutropenia [letter]. Blood. 85:852-853.
9. Kyas, U., T. Pietsch, and K. Welte. 1992. Expression of receptors for granulocyte colony-stimulating factor on neutrophils from patients with severe congenital neutropenia and cyclic neutropenia. Blood. 79:1144-1147.
10. Welte, K., and I.P. Touw. 1997. G-CSF receptor mutations in patients with severe chronic neutropenia: a step in leukemogenesis? Blood. 90:1921A.
11. Dong, F., L.H. Hoefsloot, A.M. Schelen, C.A. Broeders, Y. Meijer, A.J. Veerman, I.P. Touw, and B. Lowenberg. 1994. Identification of a nonsense mutation in the granulocyte colony-stimulating factor receptor in severe congenital neutropenia. Proc. Natl. Acad. Sci. USA. 91:4480-4484.
12. Dong, F., R.K. Brynes, N. Tidow, K. Welte, B. Lowenberg, and I.P. Touw. 1995. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia [see comments]. N. Engl. J. Med. 333:487-493.
13. Tidow, N., C. Pilz, B. Teichmann, A. Muller-Brechlin, M. Germeshausen, B. Kasper, P. Rauprich, K.W. Sykora, and K. Welte. 1997. Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Blood. 89:2369-2375.
14. Dong, F., C. van Buitenen, K. Pouwels, L.H. Hoefsloot, B. Lowenberg, and I.P. Touw. 1993. Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation. Mol. Cell. Biol. 13:7774-7781.
15. Fukunaga, R., E. Ishizaka-Ikeda, and S. Nagata. 1993. Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor. Cell. 74:1079-1087.
16. Ziegler, S.F., T.A. Bird, K.K. Morella, B. Mosley, D.P. Gearing, and H. Baumann. 1991. Distinct regions of the human granulocyte-colony-stimulating factor receptor cytoplasmic domain are required for proliferation and gene induction. Mol. Cell. Biol. 13:2384-2390.
17. Liu, F., H.Y. Wu, R. Wesselschmidt, T. Kornaga, and D.C. Link. 1996. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity. 5:491-501.
18. Barettino, D., M. Feigenbutz, R. Valcarcel, and H.G. Stunnenberg. 1994. Improved method for PCR-mediated site-directed mutagenesis. Nucleic Acids Res. 22:541-542.
19. Hug, B.A., R.L. Wesselschmidt, S. Fiering, M.A. Bender, E. Epner, M. Groudine, and T.J. Ley. 1996. Analysis of mice containing a targeted deletion of β-globin locus control region 5′ hypersensitive site 3. Mol. Cell. Biol. 16: 2906-2912.
20. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
21. Lowell, C.A., L. Fumagalli, and G. Berton. 1996. Deficiency of Src family kinases P59/61hck and p58c-fgr results in defective adhesion-dependent neutrophil functions. J. Cell Biol. 133:895-910.
22. Roberts, A., S. Foote, W. Alexander, C. Scott, L. Robb, and D. Melcalf. 1997. Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor. Blood. 89:2736-2744.
23. Homburg, C.H.E., M. de Haas, A.E. von dem Borne, A.J. Verhoeven, C.P. Reutelingsperger, and D. Roos. 1995. Human neutrophils lose their surface FcgRIII and acquire Annexin V binding sites during apoptosis in vitro. Blood. 85:532-540.
24. Koopman, G., C.P.M. Reutelingsperger, G.A.M. Kuijten, R.M.J. Keehnen, S.T. Pals, and M.H.J. van Oers. 1994. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1415-1420.
25. Martin, S.J., C.P. Reutelingsperger, A.J. McGahon, J.A. Rader, R.C. van Schie, D.M. LaFace, and D.R. Green. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus:inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182:1545-1556.
26. Bernard, T., R.E. Gale, and D.C. Linch. 1996. Analysis of granulocyte colony-stimulating factor receptor isoforms, polymorphisms and mutations in normal haemopoietic cells and acute myeloid leukaemia blasts. Br. J. Haematol. 93:527-533.
27. Carapeti, M., A. Soede-Bobok, A. Hochhaus, H. Sill, I.P. Touw, J.M. Goldman, and N.C. Cross. 1997. Rarity of dominant-negative mutations of the G-CSF receptor in patients with blast crisis of chronic myeloid leukemia or de novo acute leukemia. Leukemia. 11:1005-1008.
28. Hermans, M.H.A., C. Antonissen, A. Karis, A.C. Ward, C.D. Jongh, and I.P. Touw. 1997. Mice with a targeted G-CSF receptor mutation derived from severe congenital neutropenia have reduced absolute neutrophil counts but are not severely neutropenic. Blood. 90:1822a.
29. Liu, F., J. Poursine-Laurent, H. Wu, and D. Link. 1997. IL-6 and the G-CSF receptor are major independent regulators of granulopoiesis in vivo but are not required for lineage commitment or terminal differentiation. Blood. 90: 2583-2590.
30. de Koning, J.P., A.M. Schelen, F. Dong, C. van Buitenen, B.M. Burgering, J.L. Bos, B. Lowenberg, and I.P. Touw. 1996. Specific involvement of tyrosine 764 of human granulocyte colony-stimulating factor receptor in signal transduction mediated by p145/Shc/GRB2 or p90/GRB2 complexes. Blood. 87: 132-140.
31. Rausch, O., and C.J. Marshall. 1997. Tyrosine 763 of the murine granulocyte colony-stimulating factor receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase pathway. Mol. Cell. Biol. 17: 1170-1179.
32. Avalos, B.R. 1996. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood. 88:761-777.
33. Lord, B.I., M.H. Bronchud, S. Owens, J. Chang, A. Howell, L. Souza, and T.M. Dexter. 1989. The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc. Natl. Acad. Sci. USA. 86:9499-9503.
34. Price, T.H., G.S. Chatta, and D.C. Dale. 1996. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood. 88:335-340.
35. Lord, B.I., G. Molineux, Z. Pojda, L.M. Souza, J.-J. Mermod, and T.M. Dexter. 1991. Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. Blood. 77:2154-2159.
36. de la Chapelle, A., A.L. Traskelin, and E. Juvonen. 1993. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc. Natl. Acad. Sci. USA. 90:4495-4499.
37. Klingmuller, U., U. Lorenz, L.C. Cantley, B.G. Neel, and H.F. Lodish. 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 80:729-738.
38. Kralovics, R., K. Indrak, T. Stopka, B.W. Berman, J.F. Prchal, and J.T. Prchal. 1997. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias. Blood. 90:2057-2061.
39. Gregg, X.T., and J.T. Prchal. 1997. Erythropoietin receptor mutations and human disease. Semin. Hematol. 34:70-76.
40. Tapley, P., N.K. Shevde, P.A. Schweitzer, M. Gallina, S.W. Christianson, I.L. Lin, R.B. Stein, L.D. Shultz, J. Rosen, and P. Lamb. 1997. Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice. Exp. Hematol. 25:122-131.
41. Van Zant, G., and L. Shultz. 1989. Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev). Exp. Hematol. 17:81-87.
42. Hunter, M., and B. Avalos. 1997. A dileucine motif in the G-CSFR may mediate the dominant negative phenotype in SCN/AML. Blood. 90:1923a.